COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,450 Articles (22,835 medRxiv, 8,615 bioRxiv)

Most recent first Previous |  Page 2318: Articles 23171-23180  | Next

Comparative analysis of immune-associated genes in COVID-19, cardiomyopathy and venous thromboembolism
Castaneda, G. E., Lee, A. C., Li, W. T., Chen, C., Chakladar, J., Chang, E., Ongkeko, W.
10.1101/2020.08.28.20184234 — Posted: 2020-09-02
Severity Prediction for COVID-19 Patients via Recurrent Neural Networks
Lee, J., Ta, C., Kim, J. H., Liu, C., Weng, C.
10.1101/2020.08.28.20184200 — Posted: 2020-09-02
Test Sensitivity for Infection versus Infectiousness of SARS-CoV-2
Gans, J. S.
10.1101/2020.08.30.20184739 — Posted: 2020-09-02
Prevalence and predictors of depression, anxiety and stress symptoms among pregnant women during COVID-19-related lockdown in Abakaliki, Nigeria
Nwafor, J. I., Okedo-Alex, I. N., Ikeotuonye, A. C.
10.1101/2020.08.30.20184697 — Posted: 2020-09-02
Modeling Dynamic Network Strategies for SARS-CoV-2 Control on a Cruise Ship
Jenness, S. M., Willebrand, K. S., Malik, A. A., Lopman, B. A., Omer, S. B.
10.1101/2020.08.26.20182766 — Posted: 2020-09-01
A longitudinal study of SARS-CoV-2 infected patients shows high correlation between neutralizing antibodies and COVID-19 severity
Legros, V., Denolly, S., Vogrig, M., Boson, B., Rigaill, J., Pillet, S., Grattard, F., Gonzalo, S., Verhoeven, P., Allatif, O., Berthelot, P., Pelissier, C., Thierry, G., Botelho-Nevers, E., Paul, S., Walzer, T., Cosset, F.-L., Bourlet, T., Pozzetto, B.
10.1101/2020.08.27.20182493 — Posted: 2020-09-01
SalivaAll: Clinical validation of a sensitive test for saliva collected in healthcare and community settings with pooling utility for SARS-CoV-2 mass surveillance.
Sahajpal, N. S., Mondal, A. K., Ananth, S., Njau, A., Ahluwalia, P., Chaubey, A., Kota, V., Caspary, K., Ross, T. M., Farrell, M., Shannon, M. P., Rojiani, A. M., Kolhe, R.
10.1101/2020.08.26.20182816 — Posted: 2020-09-01 Discussion: Onsite
Racial and workplace disparities in seroprevalence of SARS-CoV-2 in Baton Rouge, Louisiana, July 15-31, 2020
Feehan, A. K., Velasco, C., Fort, D., Burton, J. H., Price-Haywood, E., Katzmarzyk, P. T., Garcia-Diaz, J., Seoane, L.
10.1101/2020.08.26.20180968 — Posted: 2020-09-01
Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia
Rosas, I., Bräu, N., Waters, M., Go, R. C., Hunter, B. D., Bhagani, S., Skiest, D., Aziz, M. S., Cooper, N., Douglas, I. S., Savic, S., Youngstein, T., Del Sorbo, L., Cubillo Gracian, A., De La Zerda, D. J., Ustianowski, A., Bao, M., Dimonaco, S., Graham, E., Matharu, B., Spotswood, H., Tsai, L., Malhotra, A.
10.1101/2020.08.27.20183442 — Posted: 2020-09-01 Discussion: Offsite
Potential reduction in transmission of COVID-19 by digital contact tracing systems
Plank, M. J., James, A., Lustig, A., Steyn, N., Binny, R. N., Hendy, S. C.
10.1101/2020.08.27.20068346 — Posted: 2020-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).